Molecular and genetic aspects of aminoglycoside-induced hearing loss

Drug Discovery Today: Disease Mechanisms

Volumn 3, Issue 1, 2006, Pages 119-124

  Talaska, Andra E ^a   Schacht, Jochen ^a   Fischel Ghodsian, Nathan ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIOXIDANT; CASPASE; ETACRYNIC ACID; GENTAMICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KANAMYCIN; MEGALIN; METHIONINE; PLACEBO; PROTEIN P50; REACTIVE OXYGEN METABOLITE; SALICYLIC ACID; STREPTOMYCIN; SUPEROXIDE DISMUTASE; SYNAPTOTAGMIN; TOBRAMYCIN;

ANTIOXIDANT ACTIVITY; CELL DEATH; CLINICAL TRIAL; DISEASE COURSE; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG COMPETITION; DRUG COST; DRUG EFFICACY; DRUG EXPOSURE; DRUG INDUCED DISEASE; DRUG PENETRATION; DRUG TISSUE LEVEL; DRUG UPTAKE; DRUG WITHDRAWAL; EAR PROTECTION; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HAIR CELL; HEALTH CARE AVAILABILITY; HEARING LOSS; HUMAN; NEPHROTOXICITY; NONHUMAN; OTOTOXICITY; PATHOGENESIS; PREVALENCE; REVIEW; RISK FACTOR; RISK REDUCTION; SPIRAL GANGLION; TINNITUS; TUBERCULOSIS;

EID: 33745906246     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2006.03.010     Document Type: Review

References (40)

1. Lerner S.A., et al. Comparative-study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin. Am. J. Med. 80 (1986) 98-104
2. Brouet G., et al. Étude expérimentale et clinique de la kanmycine dans l'infection tuberculeuse. Re Tub. Pneum. 23 (1959) 949-988
3. Fausti S.A., et al. An individualized, sensitive frequency range for early detection of ototoxicity. Ear Hearing 20 (1999) 497-505
4. Schatz A., et al. Streptomycin, a substance exhibiting antibiotic activity against gram-positive and gram-negative bacteria. Proc. Soc. Exp. Biol. Med. 55 (1944) 66-69
5. Forge A., and Schacht J. Aminoglycoside antibiotics. Audiol. Neurootol. 5 (2000) 3-22
6. Hawkins J.E., et al. The ototoxicity of dihydrostreptomycin and neomycin in the cat. Ann. Otol. Rhinol. Laryngol. 62 (1953) 1128
7. Henley C.M., and Schacht J. Pharmacokinetics of aminoglycoside antibiotics in blood, inner ear fluids and tissues and their relationship to ototoxicity. Audiology 27 (1988) 137-146
8. Aran J.M., et al. Ototoxicity of aminosides: recent results on uptake and clearance of gentamycin by sensory cells of the cochlea. Rev. Laryngol. Otol. Rhinol. 114 (1993) 125-128
9. Aran J.M., and Portmann M. Synergism between noise and ototoxic drugs: new experimental data. Bull. Acad. Natl. Med. 174 (1990) 939-944
10. Moestrup S.K., et al. Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. J. Clin. Invest. 96 (1995) 1404-1413
11. Sha S.-H., and Schacht J. Formation of reactive oxygen species following bioactivation of gentamicin. Free Radic. Biol. Med. 26 (1999) 341-347
12. Lesniak W., et al. Ternary complexes of gentamicin with iron and lipid catalyze formation of reactive oxygen species. Chem. Res. Toxicol. 18 (2005) 357-364
13. Clerici W.J., et al. Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants. Hearing Res. 98 (1996) 116-124
14. Song B.-B., et al. Iron chelators protect from aminoglycoside-induced cochleo- and vestibulotoxicity. Free Radic. Biol. Med. 25 (1998) 189-195
15. Sha S.-H., and Schacht J. Salicylate attenuates gentamicin-induced ototoxicity. Lab. Invest. 79 (1999) 807-813
16. Sha S.-H., and Schacht J. Antioxidants attenuate gentamicin-induced free-radical formation in vitro and ototoxicity in vivo: d-methionine is a potential protectant. Hearing Res. 142 (2000) 34-40
17. Sha S.-H., et al. Overexpression of copper/zinc-superoxide dismutase protects from kanamycin-induced hearing loss. Audiol. Neurootol. 6 (2001) 117-123
18. Sha S.-H., et al. Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals. Hearing Res. 155 (2001) 1-8
19. Li L., et al. Two modes of hair cell loss from the vestibular sensory epithelia of the guinea pig inner ear. J. Comp. Neurol. 355 (1995) 405-417
20. Nakagawa T., et al. Apoptosis of guinea pig cochlear hair cells following aminoglycoside treatment. Eur. Arch. Otorhinolaryngol. 255 (1998) 127-131
21. Ylikoski J., et al. Blockade of c-Jun N-terminal kinase pathway attenuates gentamicin-induced cochlear and vestibular hair cell death. Hearing Res. 163 (2002) 71-81
22. Jiang H., et al. Caspase-independent pathways of hair cell death induced by kanamycin in vivo. Cell Death Differ. 13 (2006) 20-30
23. Jiang H., et al. The NF-κB pathway protects cochlear hair cells from aminoglycoside-induced ototoxicity. J. Neurosci. Res. 79 (2005) 644-651
24. Mathog R.H., and Klein Jr. W.J. Ototoxicity of ethacrynic acid and aminoglycoside antibiotics in uremia. N. Engl. J. Med. 280 (1969) 1223-1224
25. Tan C.T., et al. Potentiation of noise-induced hearing loss by amikacin in guinea pigs. Hearing Res. 161 (2001) 72-80
26. Sliwinska-Kowalska M., et al. Effects of coexposure to noise and mixture of organic solvents on hearing in dockyard workers. J. Occup. Environ. Med. 46 (2004) 30-38
27. Hu D.-N., et al. Genetic aspects of antibiotic induced deafness: mitochondrial inheritance. J. Med. Genetics 28 (1991) 79-83
28. Prezant T.R., et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat. Gen. 4 (1993) 289-294
29. Fischel-Ghodsian N. Genetic factors in aminoglycoside toxicity. Pharmacogenomics 6 (2005) 27-36
30. Zhao H., et al. Maternally inherited aminoglycoside-induced and non-syndromic deafness associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large Chinese family. Am. J. Human Genetics 74 (2004) 139-152
31. Kobayashi K., et al. Genetic features, clinical phenotypes, and prevalence of sensorineural hearing loss associated with the 961delT mitochondrial mutation. Auris Nasus Larynx. 32 (2005) 119-124
32. Thyagarajan D. A novel mitochondrial 12SrRNA point mutation in Parkinsonism, deafness and neuropathy. Ann. Neurol. 48 (2000) 730-736
33. Tessa A., et al. Maternally inherited deafness associated with a T1095C mutation in the mDNA. Eur. J. Human Genetics 9 (2001) 147-149
34. Zhao L., et al. Clinical evaluation and sequence analysis of the complete mitochondrial genome of three Chinese patients with hearing impairment associated with the 12S rRNA T1095C mutation. Biochem. Biophys. Res. Commun. 325 (2004) 1503-1508
35. Fischel-Ghodsian N., et al. Mitochondrial gene mutations: a common predisposing factor in aminoglycoside ototoxicity. Am. J. Otolaryngol. 18 (1997) 173-178
36. Tono T., et al. Different clinical characteristics of aminoglycoside-induced profound deafness with and without the 1555 A→G mitochondrial mutation. ORL 63 (2001) 25-30
37. Braverman I., et al. Audio-vestibular findings in patients with deafness caused by a mitochondrial susceptibility mutation and precipitated by an inherited nuclear mutation or aminoglycosides. Arch. Otolaryngol. Head Neck Surg. 122 (1996) 1001-1004
38. Spangler E.A., and Blackburn E.H. The nucleotide sequence of the 17S ribosomal RNA gene of Tetrahymena thermophila and the identification of point mutations resulting in resistance to the antibiotics paromomycin and hygromycin. J. Biol. Chem. 260 (1985) 6334-6340
39. Hamasaki K., and Rando R.R. Specific binding of aminoglycosides to a human rRNA construct based on a DNA polymorphism which causes aminoglycoside-induced deafness. Biochemistry 36 (1997) 12323-12328
40. Sha, S-H., et al. Aspirin to prevent gentamicin-induced hearing loss. N. Engl. J. Med. (in press)